NCT05242094 Pulmonary Rehabilitation Implemented With VR for Post-COVID-19 Patients Status UNKNOWN Phase NA
NCT05240742 CORona (COVID-19) Follow Up Study: Epidemiology, Pathophysiology, Prediction, and Communication Status COMPLETED Phase N/A
NCT05239975 A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine Status WITHDRAWN Phase PHASE2
NCT05239806 A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine Status UNKNOWN Phase PHASE2
NCT05238454 A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine Status UNKNOWN Phase PHASE2
NCT05238441 A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine Status UNKNOWN Phase PHASE2
NCT05236478 Efficiency of an Optimized Care Organization for Fatigue Management for Patients With COVID-19. Status COMPLETED Phase N/A
NCT05236270 CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19) Status COMPLETED Phase NA
NCT05235698 Study of Vascular Endothelial Glycocalyx and Ophthalmic Injury, Prospective Cohort of Patients With Prolonged Post-COVID-19 Symptoms Status COMPLETED Phase N/A
NCT05235386 Clinical Impact of Automated Oxygen Administration on Confirmed or Suspected COVID-19 in the Emergency Department. Status UNKNOWN Phase N/A
NCT05235373 Prognostic Significance of COVID-19 MSCT Chest Findings on Short Term Disease Progression Status COMPLETED Phase N/A
NCT05234281 Concentrated Cross-disciplinary Group Intervention for Common Health Complaints (Including Post COVID-19 Fatigue) Status UNKNOWN Phase NA
NCT05233826 Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19 Status COMPLETED Phase PHASE1
NCT05231590 Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years Status COMPLETED Phase PHASE3